Pieris AG announced the successful handover of a multispecific Anticalin ® preclinical drug candidate from Pieris to Sanofi, who will be responsible for further development of the program, triggering an undisclosed payment to Pieris.
Pieris AG announced the successful handover of a multispecific Anticalin ® preclinical drug candidate from Pieris to Sanofi, who will be responsible for further development of the program, triggering an undisclosed payment to Pieris.